Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University Health Network, Toronto
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
University of Nebraska
Rutgers, The State University of New Jersey
Northwestern University
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Canadian Cancer Trials Group
University of Wisconsin, Madison
Vanderbilt-Ingram Cancer Center
Mayo Clinic
Swiss Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
The Cleveland Clinic
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
University of California, San Francisco
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Vanderbilt University Medical Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Celldex Therapeutics
Barbara Ann Karmanos Cancer Institute
Bayer
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center